{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T05:24:56Z","timestamp":1790918696327,"version":"4.1.0"},"reference-count":28,"publisher":"American Academy of Pediatrics (AAP)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,12,1]]},"abstract":"<jats:p>Buprenorphine is a partial \u03bc\u2212opioid receptor agonist that is approved for the treatment of opioid dependency. It is generally believed to be safer than methadone because of its ceiling effect on respiratory depression. As more adults in US households use buprenorphine, an increasing number of children are being exposed. We report a fatal exposure to buprenorphine in a small child that occurred after ingestion of a caretaker\u2019s buprenorphine\/naloxone. Postmortem toxicology analysis showed free serum concentrations of 52 ng\/mL and 39 ng\/mL for buprenorphine and norbuprenorphine, respectively. No other drugs were detected. Autopsy did not find signs of injury or trauma. The theoretical safety provided by the ceiling effect in respiratory depression from buprenorphine may not apply to children, and buprenorphine may cause dose-dependent respiratory depression.<\/jats:p>","DOI":"10.1542\/peds.2012-1342","type":"journal-article","created":{"date-parts":[[2012,11,6]],"date-time":"2012-11-06T04:18:14Z","timestamp":1352175494000},"page":"e1700-e1703","source":"Crossref","is-referenced-by-count":40,"title":["Buprenorphine May Not Be as Safe as You Think: A Pediatric Fatality From Unintentional Exposure"],"prefix":"10.1542","volume":"130","author":[{"given":"Hong K.","family":"Kim","sequence":"first","affiliation":[{"name":"New York University Langone Medical Center\/Bellevue Hospital Center, New York City Poison Control Center, New York, New York;"},{"name":"Department of Emergency Medicine, New York University School of Medicine, New York, New York; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Smiddy","sequence":"additional","affiliation":[{"name":"Office of Chief Medical Examiner, City of New York, Department of Forensic Pathology, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert S.","family":"Hoffman","sequence":"additional","affiliation":[{"name":"New York University Langone Medical Center\/Bellevue Hospital Center, New York City Poison Control Center, New York, New York;"},{"name":"Department of Emergency Medicine, New York University School of Medicine, New York, New York; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lewis S.","family":"Nelson","sequence":"additional","affiliation":[{"name":"New York University Langone Medical Center\/Bellevue Hospital Center, New York City Poison Control Center, New York, New York;"},{"name":"Department of Emergency Medicine, New York University School of Medicine, New York, New York; and"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"417","published-online":{"date-parts":[[2012,12,1]]},"reference":[{"issue":"5","key":"2021120823580571700_B1","doi-asserted-by":"crossref","first-page":"577","DOI":"10.2165\/00003495-200969050-00006","article-title":"Buprenorphine\/naloxone: a review of its use in the treatment of opioid dependence.","volume":"69","author":"Orman","year":"2009","journal-title":"Drugs"},{"issue":"1","key":"2021120823580571700_B2","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/sj.clpt.6100025","article-title":"Mechanism-based PK\/PD modeling of the respiratory depressant effect of buprenorphine and fentanyl in healthy volunteers.","volume":"81","author":"Yassen","year":"2007","journal-title":"Clin Pharmacol Ther"},{"issue":"2","key":"2021120823580571700_B3","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1124\/jpet.106.115972","article-title":"Pharmacokinetic-pharmacodynamic modeling of the respiratory depressant effect of norbuprenorphine in rats.","volume":"321","author":"Yassen","year":"2007","journal-title":"J Pharmacol Exp Ther"},{"issue":"1","key":"2021120823580571700_B4","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/j.1521-0391.2009.00002.x","article-title":"Methadone and buprenorphine toxicity in children.","volume":"19","author":"Boyer","year":"2010","journal-title":"Am J Addict"},{"issue":"10","key":"2021120823580571700_B5","doi-asserted-by":"crossref","first-page":"910","DOI":"10.3109\/15563650.2011.635149","article-title":"2010 Annual Report of the American Association of Poison Control Centers\u2019 National Poison Data System (NPDS): 28th Annual Report.","volume":"49","author":"Bronstein","year":"2011","journal-title":"Clin Toxicol (Phila)"},{"issue":"6","key":"2021120823580571700_B6","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1093\/jat\/22.6.430","article-title":"Buprenorphine-related deaths among drug addicts in France: a report on 20 fatalities.","volume":"22","author":"Tracqui","year":"1998","journal-title":"J Anal Toxicol"},{"issue":"7","key":"2021120823580571700_B7","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/S0009-9120(02)00304-1","article-title":"A new series of 13 buprenorphine-related deaths.","volume":"35","author":"Kintz","year":"2002","journal-title":"Clin Biochem"},{"issue":"1-2","key":"2021120823580571700_B8","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0379-0738(01)00454-6","article-title":"Deaths involving buprenorphine: a compendium of French cases.","volume":"121","author":"Kintz","year":"2001","journal-title":"Forensic Sci Int"},{"issue":"4","key":"2021120823580571700_B9","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2007-1774","article-title":"Toxicity of buprenorphine overdoses in children.","volume":"121","author":"Hayes","year":"2008","journal-title":"Pediatrics"},{"issue":"2","key":"2021120823580571700_B10","doi-asserted-by":"crossref","first-page":"e102","DOI":"10.1097\/PCC.0b013e3181f3a118","article-title":"Toddlers requiring pediatric intensive care unit admission following at-home exposure to buprenorphine\/naloxone.","volume":"12","author":"Pedapati","year":"2011","journal-title":"Pediatr Crit Care Med"},{"issue":"9","key":"2021120823580571700_B11","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1097\/PEC.0b013e31814a6aac","article-title":"Suboxone (buprenorphine\/naloxone) toxicity in pediatric patients: a case report.","volume":"23","author":"Schwarz","year":"2007","journal-title":"Pediatr Emerg Care"},{"issue":"1","key":"2021120823580571700_B12","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.annemergmed.2006.02.031","article-title":"Exploratory buprenorphine ingestion in an infant.","volume":"48","author":"Cho","year":"2006","journal-title":"Ann Emerg Med"},{"issue":"4","key":"2021120823580571700_B13","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1542\/peds.2006-0948","article-title":"Adverse effects in children after unintentional buprenorphine exposure.","volume":"118","author":"Geib","year":"2006","journal-title":"Pediatrics"},{"issue":"6","key":"2021120823580571700_B14","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1093\/bja\/aei145","article-title":"Comparison of the respiratory effects of intravenous buprenorphine and fentanyl in humans and rats.","volume":"94","author":"Dahan","year":"2005","journal-title":"Br J Anaesth"},{"issue":"2","key":"2021120823580571700_B15","doi-asserted-by":"crossref","first-page":"79","DOI":"10.2165\/00139709-200625020-00002","article-title":"Does high-dose buprenorphine cause respiratory depression? Possible mechanisms and therapeutic consequences.","volume":"25","author":"M\u00e9garbane","year":"2006","journal-title":"Toxicol Rev"},{"issue":"3","key":"2021120823580571700_B16","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1097\/ADM.0b013e3182034e31","article-title":"Illicit use of buprenorphine\/naloxone among injecting and noninjecting opioid users.","volume":"5","author":"Bazazi","year":"2011","journal-title":"J Addict Med"},{"issue":"2","key":"2021120823580571700_B17","doi-asserted-by":"crossref","first-page":"S39","DOI":"10.1016\/S0376-8716(03)00058-9","article-title":"Pharmacokinetics of the combination tablet of buprenorphine and naloxone.","volume":"70","author":"Chiang","year":"2003","journal-title":"Drug Alcohol Depend"},{"issue":"6","key":"2021120823580571700_B18","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1093\/jat\/20.6.369","article-title":"Human pharmacokinetics of intravenous, sublingual, and buccal buprenorphine.","volume":"20","author":"Kuhlman","year":"1996","journal-title":"J Anal Toxicol"},{"issue":"12","key":"2021120823580571700_B19","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.1093\/clinchem\/43.12.2292","article-title":"Subnanogram-concentration measurement of buprenorphine in human plasma by electron-capture capillary gas chromatography: application to pharmacokinetics of sublingual buprenorphine.","volume":"43","author":"Everhart","year":"1997","journal-title":"Clin Chem"},{"issue":"5","key":"2021120823580571700_B20","doi-asserted-by":"crossref","first-page":"329","DOI":"10.2165\/00003088-200443050-00005","article-title":"Pharmacokinetics and subjective effects of sublingual buprenorphine, alone or in combination with naloxone: lack of dose proportionality.","volume":"43","author":"Harris","year":"2004","journal-title":"Clin Pharmacokinet"},{"issue":"1","key":"2021120823580571700_B21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/15563659709001158","article-title":"Habitual, toxic, and lethal concentrations of 103 drugs of abuse in humans.","volume":"35","author":"Repetto","year":"1997","journal-title":"J Toxicol Clin Toxicol"},{"key":"2021120823580571700_B22","doi-asserted-by":"crossref","first-page":"s3","DOI":"10.1191\/0269216306pm1126oa","article-title":"Opioid-induced respiratory effects: new data on buprenorphine.","volume":"20","author":"Dahan","year":"2006","journal-title":"Palliat Med"},{"issue":"5","key":"2021120823580571700_B23","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1111\/j.1399-6576.1993.tb03744.x","article-title":"Comparison of the ventilatory effects of morphine and buprenorphine in children.","volume":"37","author":"Hamunen","year":"1993","journal-title":"Acta Anaesthesiol Scand"},{"issue":"5","key":"2021120823580571700_B24","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/j.1460-9592.1995.tb00311.x","article-title":"Paediatric ventilatory effects of morphine and buprenorphine revisited.","volume":"5","author":"Olkkola","year":"1995","journal-title":"Paediatr Anaesth"},{"issue":"1","key":"2021120823580571700_B25","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1097\/00000542-200607000-00012","article-title":"Naloxone reversal of buprenorphine-induced respiratory depression.","volume":"105","author":"van Dorp","year":"2006","journal-title":"Anesthesiology"},{"issue":"7","key":"2021120823580571700_B26","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1093\/jat\/27.7.527","article-title":"Buprenorphine in drug-facilitated sexual abuse: a fatal case involving a 14-year-old boy.","volume":"27","author":"Kintz","year":"2003","journal-title":"J Anal Toxicol"},{"issue":"1-3","key":"2021120823580571700_B27","doi-asserted-by":"crossref","first-page":"e8","DOI":"10.1016\/j.forsciint.2010.05.015","article-title":"Fatal poisoning due to snorting buprenorphine and alcohol consumption.","volume":"204","author":"Ferrant","year":"2011","journal-title":"Forensic Sci Int"},{"key":"2021120823580571700_B28","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.forsciint.2006.03.037","article-title":"A survey of buprenorphine related deaths in Singapore.","volume":"162","author":"Lai","year":"2006","journal-title":"Forensic Sci Int"}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/130\/6\/e1700\/896567\/peds_2012-1342.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/130\/6\/e1700\/896567\/peds_2012-1342.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,30]],"date-time":"2022-01-30T22:53:00Z","timestamp":1643583180000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/130\/6\/e1700\/30352\/Buprenorphine-May-Not-Be-as-Safe-as-You-Think-A"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,12,1]]},"references-count":28,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2012,12,1]]},"published-print":{"date-parts":[[2012,12,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.2012-1342","relation":{},"ISSN":["0031-4005","1098-4275"],"issn-type":[{"value":"0031-4005","type":"print"},{"value":"1098-4275","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,12,1]]}}}